FOLH1 and cancer: We addressed this knowledge gap and relied on the Frankfurt Metastatic Cancer Database of the Prostate (FRAMCAP) to elaborate cancer-control outcomes such as PFS and OS in [177Lu]Lu-PSMA-treated mCRPC patients.